ANNEXON, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
ANNEXON, INC. (ANNX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 5.54 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-12
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 1.34M shares, a 90.06% increase year-over-year.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 4.20M shares, a 23.03% decline year-over-year.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 147.00K shares, a 92.79% decline year-over-year.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 60.00K shares, a 94.62% decline year-over-year.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 6.37M shares, a 5.68% decline from fiscal 2024.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 6.75M shares, a 159.40% increase from fiscal 2023.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 2.60M shares, a 30.94% decline from fiscal 2022.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 3.77M shares, a 31.22% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.34M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 5.54M shares 10-Q · filed 2026-08-12 | 5.68M shares derived: sum of 3 quarters · filed 2026-08-12 | 5.74M shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 4.20M shares 10-Q · filed 2026-05-07 | 4.35M shares derived: sum of 2 quarters · filed 2026-05-07 | 4.41M shares derived: sum of 3 quarters · filed 2026-05-07 | 5.11M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 147.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 207.00K shares derived: sum of 2 quarters · filed 2026-03-30 | 911.00K shares derived: sum of 3 quarters · filed 2026-03-30 | 6.37M shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 60.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | 764.00K shares derived: sum of 2 quarters · filed 2025-11-10 | 6.22M shares 10-Q · filed 2025-11-10 | 8.26M shares derived: sum of 4 quarters · filed 2025-11-10 |
| 2025-06-30 | 704.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 6.16M shares 10-Q · filed 2025-08-14 | 8.20M shares derived: sum of 3 quarters · filed 2025-08-14 | 9.31M shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 5.46M shares 10-Q · filed 2025-05-12 | 7.50M shares derived: sum of 2 quarters · filed 2025-05-12 | 8.61M shares derived: sum of 3 quarters · filed 2025-05-12 | 9.08M shares derived: sum of 4 quarters · filed 2025-05-12 |
| 2024-12-31 | 2.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 3.15M shares derived: sum of 2 quarters · filed 2025-03-03 | 3.63M shares derived: sum of 3 quarters · filed 2025-03-03 | 6.75M shares 10-K · filed 2025-03-03 |
| 2024-09-30 | 1.11M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 1.59M shares derived: sum of 2 quarters · filed 2024-11-14 | 4.71M shares 10-Q · filed 2024-11-14 | 4.89M shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | 474.52K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | 3.60M shares 10-Q · filed 2024-08-12 | 3.78M shares derived: sum of 3 quarters · filed 2024-08-12 | 4.18M shares derived: sum of 4 quarters · filed 2024-08-12 |
| 2024-03-31 | 3.12M shares 10-Q · filed 2024-05-13 | 3.31M shares derived: sum of 2 quarters · filed 2024-05-13 | 3.71M shares derived: sum of 3 quarters · filed 2024-05-13 | 3.97M shares derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-12-31 | 183.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | 588.60K shares derived: sum of 2 quarters · filed 2024-03-26 | 851.60K shares derived: sum of 3 quarters · filed 2024-03-26 | 2.60M shares 10-K · filed 2024-03-26 |
| 2023-09-30 | 405.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 668.00K shares derived: sum of 2 quarters · filed 2023-11-13 | 2.42M shares 10-Q · filed 2023-11-13 | 2.54M shares derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | 263.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 2.01M shares 10-Q · filed 2023-08-07 | 2.14M shares derived: sum of 3 quarters · filed 2023-08-07 | 3.31M shares derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | 1.75M shares 10-Q · filed 2023-05-08 | 1.87M shares derived: sum of 2 quarters · filed 2023-05-08 | 3.05M shares derived: sum of 3 quarters · filed 2023-05-08 | 3.57M shares derived: sum of 4 quarters · filed 2023-05-08 |
| 2022-12-31 | 122.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 1.30M shares derived: sum of 2 quarters · filed 2023-03-06 | 1.82M shares derived: sum of 3 quarters · filed 2023-03-06 | 3.77M shares 10-K · filed 2023-03-06 |
| 2022-09-30 | 1.18M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 1.70M shares derived: sum of 2 quarters · filed 2022-11-03 | 3.65M shares 10-Q · filed 2022-11-03 | 3.83M shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 521.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 2.47M shares 10-Q · filed 2022-08-08 | 2.65M shares derived: sum of 3 quarters · filed 2022-08-08 | 3.22M shares derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | 1.95M shares 10-Q · filed 2022-05-09 | 2.13M shares derived: sum of 2 quarters · filed 2022-05-09 | 2.69M shares derived: sum of 3 quarters · filed 2022-05-09 | 3.20M shares derived: sum of 4 quarters · filed 2022-05-09 |
| 2021-12-31 | 182.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 748.80K shares derived: sum of 2 quarters · filed 2022-03-01 | 1.26M shares derived: sum of 3 quarters · filed 2022-03-01 | 2.87M shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 566.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 1.08M shares derived: sum of 2 quarters · filed 2021-11-09 | 2.69M shares 10-Q · filed 2021-11-09 | 3.08M shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | 510.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 2.12M shares 10-Q · filed 2021-08-16 | 2.52M shares derived: sum of 3 quarters · filed 2021-08-16 | 3.02M shares derived: sum of 4 quarters · filed 2021-08-16 |
| 2021-03-31 | 1.61M shares 10-Q · filed 2021-05-17 | 2.01M shares derived: sum of 2 quarters · filed 2021-05-17 | 2.51M shares derived: sum of 3 quarters · filed 2021-05-17 | |
| 2020-12-31 | 395.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 892.92K shares derived: sum of 2 quarters · filed 2021-03-25 | 1.91M shares 10-K · filed 2021-03-25 | |
| 2020-09-30 | 497.82K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | 1.52M shares 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | 1.02M shares 10-Q · filed 2020-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |